In contrast to benign insulinoma, malignant or metastatic insulinoma often lack GLP-1 receptor while overexpressing SSTR-2, making them potentially suitable for SSTR-2 based PRRT [85, 89]. Here, SSTR2 is linked to pancreatic insulinoma.